1. Home
  2. LZ vs EVO Comparison

LZ vs EVO Comparison

Compare LZ & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LegalZoom.com Inc.

LZ

LegalZoom.com Inc.

HOLD

Current Price

$6.24

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.22

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LZ
EVO
Founded
2001
1993
Country
United States
Germany
Employees
N/A
4553
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
934.1M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
LZ
EVO
Price
$6.24
$3.22
Analyst Decision
Hold
Strong Buy
Analyst Count
9
1
Target Price
$9.79
$7.00
AVG Volume (30 Days)
2.6M
82.5K
Earning Date
05-06-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$756,043,000.00
N/A
Revenue This Year
$11.50
$1.29
Revenue Next Year
$7.11
$11.31
P/E Ratio
$75.19
N/A
Revenue Growth
10.88
N/A
52 Week Low
$5.28
$2.31
52 Week High
$12.40
$4.80

Technical Indicators

Market Signals
Indicator
LZ
EVO
Relative Strength Index (RSI) 52.44 68.48
Support Level $5.44 $2.87
Resistance Level $6.47 $3.78
Average True Range (ATR) 0.31 0.08
MACD 0.09 0.11
Stochastic Oscillator 94.50 97.97

Price Performance

Historical Comparison
LZ
EVO

About LZ LegalZoom.com Inc.

LegalZoom.com Inc is an online provider of services that meet the legal needs of small businesses and consumers in the United States. The company also offers services that include ongoing compliance and tax advice and filings, business licenses, accounting, virtual mailbox and e-signature solutions, trademark filings, and estate plans.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: